Aprogen Biologics Inc. (KRX:003060)
293.00
-14.00 (-4.56%)
At close: Mar 4, 2026
-60.08% (1Y)
| Market Cap | 60.65B |
| Revenue (ttm) | 74.91B |
| Net Income (ttm) | -194.29B |
| Shares Out | 197.57M |
| EPS (ttm) | -983.23 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,193,407 |
| Average Volume | 4,771,451 |
| Open | 298.00 |
| Previous Close | 307.00 |
| Day's Range | 272.00 - 301.00 |
| 52-Week Range | 272.00 - 840.00 |
| Beta | -0.03 |
| RSI | 22.15 |
| Earnings Date | Mar 16, 2026 |